ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 86 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $576,000 | +31.5% | 77,727 | -25.9% | 0.40% | +27.4% |
Q2 2020 | $438,000 | +29.2% | 104,926 | -23.5% | 0.32% | +5.7% |
Q1 2020 | $339,000 | -33.9% | 137,230 | +55.4% | 0.30% | -33.9% |
Q4 2019 | $513,000 | +100.4% | 88,314 | +82.1% | 0.45% | +80.2% |
Q3 2019 | $256,000 | +5.8% | 48,502 | +20.4% | 0.25% | +14.5% |
Q2 2019 | $242,000 | -19.1% | 40,270 | +21.8% | 0.22% | -29.9% |
Q1 2019 | $299,000 | +63.4% | 33,059 | +50.0% | 0.31% | +62.7% |
Q4 2018 | $183,000 | – | 22,039 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |